Search

Your search keyword '"Nilsson AC"' showing total 215 results

Search Constraints

Start Over You searched for: Author "Nilsson AC" Remove constraint Author: "Nilsson AC"
215 results on '"Nilsson AC"'

Search Results

2. A population-based prospective study of optic neuritis

4. Predictive values of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in relation to serological aspects of the ACR/EULAR 2010 classification criteria for rheumatoid arthritis.

5. Effects of inogatran, a new low-molecular-weight thrombin inhibitor, in rat models of venous and arterial thrombosis, thrombolysis and bleeding time

9. Early activation of humoral proteolytic systems in patients with multiple trauma

10. Thrombosis after hip replacement: Relationship to the fibrinolytic system

11. Haemostatic Clot Formation at Anastomosis of Synthetic Venous Graft in Defibrinogenated Dogs: A Scanning Electron Microscopic Study

12. Defibrinogenation as an alternative to heparinization during prolonged extracorporeal circulation in the dog

13. Administration of plasma to dogs defibrinogenated with defibraseR

14. A sensitive assay for tissue plasminogen activator activity in plasma, using adsorption on lysine-sepharose

15. Determination of Fast-Acting Plasmin Inhibitor (α2-Antiplasmin) in Plasma from Patients with Tendency to Thrombosis and Increased Fibrinolysis

16. Activity of the alpha 2-macroglobulin-plasmin complex on the plasmin specific substrate H-D-Val-Leu-Lys-p-nitroanilide

17. Studies during rapid defibrinogenation followed by intra-arterial infusion of plasma on the pulmonary and renal function in dogs

18. TOTAL HIP REPLACEMENT AND DEEP VEIN THROMBOSIS - RELATIONSHIP TO THE FIBRINOLYTIC SYSTEM

19. Intrapleural instillation of streptokinase. Effects on systemic fibrinolysis

20. Platelet reactivity, fibrinogen and smoking

21. Anticoagulation During Six Hours of Extracorporeal Perfusion. Comparison between Heparinization and Defibrinogenation

22. Acute hepatitis non-A, non-B following administration of factor VIII concentrates

23. Pseudoendothelium formation in expanded polytetrafluoroethylene grafts implanted in the inferior vena cava of normal and defibrinogenated dogs

25. Clinical severity of Mycoplasma pneumoniae (MP) infection is associated with bacterial load in oropharyngeal secretions but not with MP genotype.

26. 'Does this fecal microbiota transplant work?' Quality assurance of capsule based fecal microbiota transplant production.

27. Humoral and cellular immune response from first to fourth SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patients-a longitudinal cohort study.

28. Outcomes of Adjunctive Corticosteroid Treatment on Hypoxemic Adults Hospitalised for Mycoplasma pneumoniae Pneumonia: a Retrospective Cohort Study.

29. Sotrovimab lost neutralization efficacy against SARS-CoV-2 subvariants but remained clinically effective: Were monoclonal antibodies against COVID-19 rejected too early?

30. Prolonged Fatigue and Mental Health Challenges in Critical COVID-19 Survivors.

31. Staphylococcus aureus carriage and prevalence of skin and soft tissue infections among people who inject drugs: a longitudinal study.

32. Initial screening for neuronal autoantibodies and their putative impact on survival in patients with small-cell lung cancer.

33. SARS-CoV-2 Antibodies in Breastmilk Three and Six Months Postpartum in Relation to the Trimester of Maternal SARS-CoV-2 Infection-An Exploratory Study.

34. Mortality of the Danish Nationwide AQP4 Antibody-Seropositive Neuromyelitis Optica Spectrum Disorder Patient Cohort.

35. Tick-borne encephalitis as a trigger for anti-N-Methyl-d-aspartate receptor encephalitis.

36. Dynamics of inflammation-associated plasma proteins following faecal microbiota transplantation in patients with psoriatic arthritis and healthy controls: exploratory findings from the FLORA trial.

37. Pathophysiological Effects of Autoantibodies in Autoimmune Encephalitides.

38. Humoral antibody response following mRNA vaccines against SARS-CoV-2 in solid organ transplant recipients; a status after a fifth and bivalent vaccine dose.

39. Small Intestinal Permeability and Metabolomic Profiles in Feces and Plasma Associate With Clinical Response in Patients With Active Psoriatic Arthritis Participating in a Fecal Microbiota Transplantation Trial: Exploratory Findings From the FLORA Trial.

40. Low protection from breakthrough SARS-CoV-2 infection and mild disease course in ocrelizumab-treated patients with multiple sclerosis after three mRNA vaccine doses.

41. SARS-CoV-2 and autoantibodies in the cerebrospinal fluid of COVID-19 patients: prospective multicentre cohort study.

42. Management of influenza - updated Swedish guidelines for antiviral treatment.

43. A pilot phase 2a, randomized, double-blind, placebo-controlled study to explore the antiviral activity, clinical outcomes, safety, and tolerability of rilematovir at two dose levels in non-hospitalized adults with respiratory syncytial virus infection.

44. Response to: 'Correspondence on 'Safety and efficacy of faecal microbiota transplantation for active peripheral psoriatic arthritis: an exploratory randomised placebo-controlled trial'' by McGonagle et al .

45. Paraneoplastic neurologic syndromes.

46. Immunogenicity and risk of disease flare after a three-dose regimen with SARS-CoV-2 vaccination in patients with systemic lupus erythematosus: results from the prospective cohort study COVAC-SLE.

48. Antineuronal antibodies in cerebrospinal fluid and serum of 104 patients with psychotic disorders compared to 104 individually matched healthy controls.

49. Salivary gland ultrasound is associated with the presence of autoantibodies in patients with Sjögren's syndrome: A Danish single-centre study.

50. Humoral immune response following a third SARS-CoV-2 mRNA vaccine dose in solid organ transplant recipients compared with matched controls.

Catalog

Books, media, physical & digital resources